Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05803564

Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm.

Clinical Application of a New Technique of Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
Lifetech Scientific (Shenzhen) Co., Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A First in man study to evaluate the safety and efficacy of thoracoabdominal aortic stent system for endovascular treatment of thoracoabdominal aortic dissecting aneurysm.

Detailed description

The study is mainly for patients with thoraco-abdominal aortic dissecting aneurysm, and all subjects who passed the screening and signed the informed consent will be enrolled. Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with thoracoabdominal aortic stent system. Patients will be followed up at discharge, 1 month, 6 months, 12 months after the implantation.

Conditions

Interventions

TypeNameDescription
DEVICEThoracoabdominal aortic stent systemPatients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with thoracoabdominal aortic stent system.

Timeline

Start date
2021-10-01
Primary completion
2026-11-01
Completion
2027-10-01
First posted
2023-04-07
Last updated
2025-06-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05803564. Inclusion in this directory is not an endorsement.